Accès ouvert
2021
article
OpenAlex
Laura Delvasto-Núñez, Dorina Roem, Kamran Bakhtiari, Gerard van Mierlo et autres
Abstract Hemolytic disorders characterized by complement-mediated intravascular hemolysis, such as autoimmune hemolytic anemia and paroxysmal nocturnal hemoglobinuria, are often complicated by life-threatening thromboembolic complications. Severe hemolytic episodes result in the release of red blood cell (RBC)-derived proinflammatory and oxidatively reactive mediators (e.g., …
nl, ch
(code pays fourni par la source)
Accès ouvert
2021
article
OpenAlex
Ilse Jongerius, Sacha Zeerleder, Laura Delvasto-Núñez, Dorina Roem et autres
Abstract Hemolytic disorders characterized by complement-mediated intravascular hemolysis, such as autoimmune hemolytic anemia and paroxysmal nocturnal hemoglobinuria, are often complicated by life-threatening thromboembolic complications. Severe hemolytic episodes result in the release of red blood cell (RBC)-derived proinflammatory and oxidatively reactive mediators (e.g., …
nl, ch
(code pays fourni par la source)
Accès ouvert
2021
article
OpenAlex
Arun Dhillon, Justin C. Deme, Emily Furlong, Dorina Roem et autres
The structure of a 10-kDa protein complex is one of the smallest to be determined using cryo-electron microscopy at high resolution. The structure reveals that C1-INH is sequestered in an inactivated state by burial of the reactive center loop in Vag8. By …
gb, nl
(code pays fourni par la source)
Accès ouvert
2021
article
OpenAlex
Sacha Zeerleder, Ruchira Engel, Tao Zhang, Dorina Roem et autres
Correct glycosylation of proteins is essential for production of therapeutic proteins as glycosylation is important for protein solubility, stability, half-life and immunogenicity. The heavily glycosylated plasma protein C1-inhibitor (C1-INH) is used in treatment of hereditary angioedema attacks. In this study, we used …
ch, nl
(code pays fourni par la source)
Accès ouvert
2020
preprint
OpenAlex
Arun Dhillon, Justin C. Deme, Emily Furlong, Dorina Roem et autres
Abstract Complement, contact activation, coagulation, and fibrinolysis are serum protein cascades that need strict regulation to maintain human health. Serum glycoprotein, C1-inhibitor (C1-INH) is a key regulator (inhibitor) of serine proteases of all the above-mentioned pathways. Recently, an autotransporter protein, Virulence Associated …
gb, us, nl
(code pays fourni par la source)
Accès ouvert
2019
article
OpenAlex
D. Ponard, Christine Gaboriaud, Delphine Charignon, Arije Ghannam et autres
C1 inhibitor (C1Inh) deficiency is responsible for hereditary angioedema (C1-INH-HAE) and caused by variants of the SERPING1/C1INH/C1NH gene. C1Inh is the major control of kallikrein-kinin system. C1Inh deficiency leads to its uncontrolled activation, with subsequent generation of the vasoactive peptide bradykinin. This …
fr, nl, es
(code pays fourni par la source)
Accès ouvert
2018
article
OpenAlex
Ruchira Engel, Laura Delvasto-Núñez, Dorina Roem, Gerard van Mierlo et autres
Background C1-inhibitor (C1-inh) therapeutics can reduce neutrophil activity in various inflammatory conditions. This ‘novel’ anti-inflammatory effect of C1-inh is attributed to the tetrasaccharide sialyl LewisX (SLeX) present on its N-glycans. Via SLeX, C1-inh is suggested to interact with selectins on inflamed endothelium …
nl, ch
(code pays fourni par la source)
Accès ouvert
2017
article
OpenAlex
Ingrid Stroo, Jack Yang, Adam A. Anas, J. Daan de Boer et autres
C1 esterase inhibitor (C1-INH) can inhibit multiple pathways (complement, contact-kinin, coagulation, and fibrinolysis) that are all implicated in the pathophysiology of asthma. We explored the effect of human plasma-derived C1-INH on allergic lung inflammation in a house dust mite (HDM) induced asthma …
nl
(code pays fourni par la source)
2015
article
OpenAlex
Ruchira Engel, Laura Delvasto Nunez, Dorina Roem, Gerard van Mierlo et autres
Abstract BACKGROUND: The plasma protein C1-inhibitor (C1-inh), belongs to the serpin superfamily and is the major inhibitor of the proteases of the complement and contact phase pathways. Hereditary or acquired deficiency of functional C1-inh results in angioedema episodes in affected individuals due …
nl
(code pays fourni par la source)
2015
article
OpenAlex
Ruchira Engel, Irma Rensink, Dorina Roem, Mieke C. Brouwer et autres
nl
(code pays fourni par la source)
Accès ouvert
2013
article
OpenAlex
Reindert W. Emmens, Benno A. Naaijkens, Dorina Roem, Klaas Kramer et autres
CONTEXT: C1-esterase inhibitor (C1-inh) therapy is currently administered to patients with C1-inh deficiency through intravenous injections. The possibility of subcutaneous administration is currently being explored since this would alleviate need for hospitalization and increase mobility and well-being of patients. Recently, it was …
nl, in
(code pays fourni par la source)
Accès ouvert
2006
article
OpenAlex
Catherine S. C. Bouman, Anne-Cornélie JM de Pont, Joost C.M. Meijers, Kamran Bakhtiari et autres
INTRODUCTION: The mechanism of coagulation activation during continuous venovenous hemofiltration (CVVH) has not yet been elucidated. Insight into the mechanism(s) of hemostatic activation within the extracorporeal circuit could result in a more rational approach to anticoagulation. The aim of the present study …
nl
(code pays fourni par la source)